纳武单抗联合化疗和纳武单抗联合伊匹单抗治疗食管癌的长期结果

{"title":"纳武单抗联合化疗和纳武单抗联合伊匹单抗治疗食管癌的长期结果","authors":"Robert van den Heuvel","doi":"10.55788/c98bf0a6","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":142739,"journal":{"name":"Medicom Conference Report ASCO GI 2023","volume":"61 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Long-term results for nivolumab plus chemotherapy and nivolumab plus ipilimumab in oesophageal cancer\",\"authors\":\"Robert van den Heuvel\",\"doi\":\"10.55788/c98bf0a6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":142739,\"journal\":{\"name\":\"Medicom Conference Report ASCO GI 2023\",\"volume\":\"61 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicom Conference Report ASCO GI 2023\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.55788/c98bf0a6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicom Conference Report ASCO GI 2023","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55788/c98bf0a6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}